Caduceus Software Systems Corp. Confirms World-Wide Licensing Agreement
20 Décembre 2011 - 2:00PM
Business Wire
Caduceus Software Systems Corp. (Caduceus) (OTCBB: CSOC) -
(The Company) confirms the terms of the Licensing Agreement
between Sygnit and Caduceus.
Due to the numerous inquiries received by our Investor Relations
firm, the company believes it is important to summarize, for our
shareholders, the terms of our Licensing Agreement with Sygnit
Corporation. The Agreement is a world-wide Licensing Agreement that
allows Caduceus to have complete control over the future
development of Caduceus MMS.
On June 9, 2011, we entered into a Licensing Agreement with
Sygnit Corporation, the Agreement is an exclusive Marketing, Sales
and Distribution agreement for the software for a period of 5
years. In addition, this contract includes all Intellectual
Property (IP) rights for the software. During this period, Sygnit
therefore forfeits its rights to use the IP for its business and
shall not sell or agree to sell all or any portion of the IP Rights
to anyone other than Caduceus Software Systems Corp. Also, all
existing trademarks and registrations in the countries where they
were filed will be kept in force for a period of 10 years from the
date the Agreement was signed. Finally, Caduceus shall pursue the
use of Sygnit’s trademark on all the products produced by
Sygnit.
CLAUSES OF OWNERSHIP
Caduceus acknowledges that Sygnit is, and at all times shall
remain, the sole and exclusive owner of all rights, title and
interest, throughout the world, in and to all IP Rights, and any
copies of the IP Rights, whether made on or behalf of Licensor or
Licensee.
In case Sygnit decides to sell the IP Rights, they shall give
Caduceus a first right of purchase for the Rights and the
associated technology for as long as this Licensing Agreement is in
effect, in the event that:
- Sygnit or a majority interest in Sygnit
is sold,
- Sygnit intends to sell the IP Rights,
and the associated technology or,
- Sygnit affects any:
- Merger or consolidation of Sygnit with
or into another entity,
- Sale of all or substantially all of
Sygnit’s assets in one or a series of related transactions,
- Any time Sygnit’s shareholders are
permitted to tender or exchange their shares for other securities,
cash or property,
- Reclassification of Sygnit’s shares or
any compulsory share exchange pursuant to which Sygnit’s shares are
effectively converted into or exchanged for other securities, cash
or property.
- Caduceus or the majority interest in
Caduceus is being acquired by a company in which the present
shareholders of Caduceus are not a part of.
“This Agreement with a group like Sygnit who’s understanding and
abilities of writing medical software is a great step in creating a
dynamic line of software products for Caduceus,” offered Derrick
Gidden, President of Caduceus Software Systems, “it is a
momentum-building move for our Company.”
About Us
Caduceus Software Systems Corp. (www.caduceusco.com) is a
software company that specializes in developing an all-in-one
solution for private practitioners and doctors. We are in the
healthcare information management industry. We are headquartered in
the United Kingdom, specifically located in the metropolitan city
of Birmingham. Our company was created as we saw an urgent need for
better patient care throughout the world. General practitioners are
using unsophisticated software which acts as more administrative
than acting as a time-saving tool. We are called Caduceus, which is
the well-known insignia used by medical professionals.
Further information on the Company can be found at www.sec.gov
and the company’s website at www.caduceusco.com.
Safe Harbor Statement
All statements contained in this press release, other than
statements of historical fact, are forward-looking statements,
including those regarding: Caduceus Software Systems Inc. products,
services, capabilities, performance, opportunities, development and
business outlook, guidance on our future financial results and
other projections or measures of our future performance; the amount
and timing of the benefits expected from strategic initiatives and
acquisitions or from deployment of new or updated technologies,
products, services or applications; and other potential sources of
additional revenue. These statements are based on our current plans
and expectations and involve risks and uncertainties that could
cause actual future events or results to be different than those
described in or implied by such forward-looking statements. These
risks and uncertainties include those relating to: lack of
operating history, transitioning from a development company to an
operating company, difficulties in distinguishing Caduceus Software
Systems Inc. products and services, ability to deploy Caduceus
Software Systems Inc. services and products, market acceptance of
our products and services; operational difficulties relating to
combining acquired companies and businesses; our ability to form
and maintain mutually beneficial relationships with customers and
strategic partners; changes in economic, political or regulatory
conditions or other trends affecting the healthcare, Internet,
information technology and healthcare and pharmaceutical
industries, and our ability to attract and retain qualified
personnel. Further information about these matters can be found in
our Securities and Exchange Commission filings. We expressly
disclaim any intent or obligation to update these forward-looking
statements.
Caduceus Software Systems (PK) (USOTC:CSOC)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Caduceus Software Systems (PK) (USOTC:CSOC)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025